SCHEMBL29624209

SCHEMBL29624209

NC(=O)C(CCCCCCCCCC(CCCCCCCCCCC(=O)O)C(=O)O)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 8/20 0.53
LMNA P02545 3/20 0.44
ALDH1A1 P00352 2/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
PMP22 Q01453 1/20 0.44
GSTK1 Q9Y2Q3 1/20 0.43
ENPEP Q07075 1/20 0.43
MEN1 O00255 1/20 0.42
PLG P00747 1/20 0.42
THRB P10828 1/20 0.42
ALOX15 P16050 1/20 0.42
SLC6A2 P23975 1/20 0.42
RECQL P46063 1/20 0.42
SLC6A3 Q01959 1/20 0.42
KMT2A Q03164 1/20 0.42
FFAR4 Q5NUL3 1/20 0.42
CPB2 Q96IY4 1/20 0.42
FFAR1 O14842 1/20 0.42
BHMT Q93088 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29624210 0.92 LMNA (0.52) LMNAALDH1A1TSHRNFKB1PMP22
SCHEMBL19049818 0.86 FOLH1 (0.67) FOLH1LMNAALDH1A1TSHRNFKB1
SCHEMBL8639831 0.86 FOLH1 (0.67) FOLH1LMNAALDH1A1TSHRNFKB1
SCHEMBL28306269 0.86 FOLH1 (0.67) FOLH1LMNAALDH1A1TSHRNFKB1
SCHEMBL3823763 0.86 FOLH1 (0.67) FOLH1LMNAALDH1A1TSHRNFKB1
SCHEMBL11769103 0.86 FOLH1 (0.67) FOLH1LMNAALDH1A1TSHRNFKB1
SCHEMBL1234699 0.86 FOLH1 (0.67) FOLH1LMNAALDH1A1TSHRNFKB1
SCHEMBL30681842 0.86 FOLH1 (0.67) FOLH1LMNAALDH1A1TSHRNFKB1
SCHEMBL11620147 0.84 FOLH1 (0.65) FOLH1LMNATSHRNFKB1PMP22
SCHEMBL11309412 0.84 FOLH1 (0.65) FOLH1LMNATSHRNFKB1PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066132-A1 NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES NOVARTIS AG (CH) 2024-02-29 US disclosed
US-11752211-B2 Fatty acids and their use in conjugation to biomolecules NOVARTIS AG (CH) 2023-09-12 US disclosed
EP-3988170-A1 FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES Novartis AG (CH) 2022-04-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066132-A1 NOVEL FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES FABP1, FABP2, FABP3 FOLH1 1189/4885LMNA 1459/4885ALDH1A1 849/4885
US-11752211-B2 Fatty acids and their use in conjugation to biomolecules FABP1, FABP2, FABP3 FOLH1 1283/4885LMNA 1424/4885ALDH1A1 907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.